文献速递间质性肺疾病

进行性纤维化间质性肺病的肺功能轨迹

Lung function trajectory in progressive fibrosing interstitial lung disease.
PubMed 文献 · Eur Respir J · 2022-06-16

该多中心回顾性队列研究纳入1227例纤维化间质性肺病患者,评估满足不同进行性纤维化间质性肺病(PF-ILD)标准后1年内用力肺活量(FVC)的变化。结果显示9条标准中6条与FVC年变化差异相关,影像学纤维化进展(单独或联合其他特征)预示FVC下降最大,且变化因ILDs亚型而异,结缔组织病相关ILD(CTD-ILD)满足多数标准后FVC变化较小。

要点

  • 9条PF-ILD标准中6条与后续1年FVC变化差异独立相关。
  • 影像学纤维化进展(单独或联合)预示最大FVC下降。
  • CTD-ILD满足多数标准后FVC变化小,其他ILDs变化显著更大。

核心结论

  • 满足不同PF-ILD标准后近期FVC变化异质,且受ILD亚型显著影响。
  • 研究结果提示应用PF-ILD标准时应考虑ILD亚型,并可优化临床试验设计。

研究设计与样本

  • 回顾性多中心纵向队列分析,纳入美国3中心(测试队列)和英国1中心(验证队列)连续患者。
  • 纳入纤维化CTD-ILD、慢性过敏性肺炎和特发性间质性肺炎患者,共1227例,以CTD-ILD为主。
  • 采用联合模型估计满足PF-ILD标准后1年FVC变化。

主要发现

  • 9条PF-ILD标准中6条与满足后1年FVC变化差异相关。
  • 影像学纤维化进展单独或联合其他特征,与后续FVC最大下降相关。
  • FVC变化因ILD亚型显著不同:CTD-ILD满足多数标准后FVC变化小,其他ILDs变化显著更大。
  • 按影像学模式或免疫抑制剂暴露分层后,结果无显著变化。

关键数值与推荐

  • 9条PF-ILD标准中6条与差异1年FVC变化相关,具体标准未在摘要中列出。
  • 影像学纤维化进展(单独或联合)与最大后续FVC下降相关。

临床怎么用

  • 应用PF-ILD标准时应考虑ILD亚型,尤其CTD-ILD满足标准后FVC变化可能较小。
  • 影像学纤维化进展可作为预示FVC下降的重要指标,用于临床监测和试验设计。

局限性

  • 回顾性研究设计。
  • 摘要未报告具体FVC变化数值、置信区间及P值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proposed criteria for progressive fibrosing interstitial lung disease (PF-ILD) have been linked to increased mortality risk, but lung function trajectory after satisfying individual criteria remains unknown. Because survival is rarely employed as the primary end-point in therapeutic trials, identifying PF-ILD criteria that best predict subsequent change in forced vital capacity (FVC) could improve clinical trial design. METHODS: A retrospective, multicentre longitudinal cohort analysis was performed in consecutive patients with fibrotic connective tissue disease-associated ILD (CTD-ILD), chronic hypersensitivity pneumonitis and idiopathic interstitial pneumonia at three US centres (test cohort) and one UK centre (validation cohort). 1-year change in FVC after satisfying proposed PF-ILD criteria was estimated using joint modelling. Subgroup analyses were performed to determine whether results varied across key subgroups. RESULTS: 1227 patients were included, with CTD-ILD predominating. Six out of nine PF-ILD criteria were associated with differential 1-year change in FVC, with radiological progression of fibrosis, alone and in combination with other features, associated with the largest subsequent decline in FVC. Findings varied significantly by ILD subtype, with CTD-ILD demonstrating little change in FVC after satisfying most PF-ILD criteria, while other ILDs showed significantly larger changes. Findings did not vary after stratification by radiological pattern or exposure to immunosuppressant therapy. Near-term change in FVC after satisfying proposed PF-ILD criteria was heterogeneous depending on the criterion assessed and was strongly influenced by ILD subtype. CONCLUSIONS: These findings may inform future clinical trial design and suggest ILD subtype should be taken into consideration when applying PF-ILD criteria.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Oldham JM, Lee CT, Wu Z, et al. Lung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J. 2022. PMID: 34737223. doi:10.1183/13993003.01396-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。